Skip to main content
SpringerLink
Log in

Comparison analysis between haplo identical stem cell transplantation and matched sibling donor stem cell transplantation for high-risk acute myeloid leukemia in first complete remission

  • Research Paper
  • Published:
Science China Life Sciences Aims and scope Submit manuscript

Abstract

In order to compare the effect between haploidentical (HID) stem cell transplantation (HSCT) and matched sibling donor (MSD) stem cell transplantation for high-risk acute myeloid leukemia (AML) in first complete remission status (CR1), we retrospectively studied 170 cases who received stem cell transplantation from Jan 2008 to Jul 2015 in Peking University People’s Hospital. We divided all cases into MSD group (43 cases) and HID (127 cases) group. Patients in HID and MSD group displayed similar baseline characteristics except for age distribution. There were no statistic differences for overall survival (OS), cumulative incidence of relapse, leukemia free survival (LFS), transplantation related mortality (TRM) between HID and MSD group. The 3-year OS, LFS for all patients was 63.9% and 59.7% respectively. Multivariate analysis showed that grade III-IV acute graft versus host disease (aGVHD) was an independent risk factor for treatment related mortality (HR=8.134, 95% CI: 3.210–20.611, P<0.001), monosomy/complex chromosomal karyotype and white blood cell count more than 50×109 L−1 were two independent factors for relapse (HR=1.533, 95% CI: 1.040–2.260, P=0.031) (HR=1.004, 95% CI: 1.001–1.008, P=0.015). Grade III-IV aGVHD was an independent factor for mortality (HR=3.184, 95% CI: 1.718–5.902, P<0.001). These results demonstrated some risk factors for high-risk AML leukemia transplantation and indicated for AML patients in CR1 status, haplo stem cell transplantation could have the same therapeutic effect as MSD transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Anelli, L., Pasciolla, C., Zagaria, A., Specchia, G., and Albano, F. (2017). Monosomal karyotype in myeloid neoplasias: a literature review. Onco Targets Ther 10, 2163–2171.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Araki, D., Wood, B.L., Othus, M., Radich, J.P., Halpern, A.B., Zhou, Y., Mielcarek, M., Estey, E.H., Appelbaum, F.R., and Walter, R.B. (2016). Allogeneic hematopoietic cell transplantation for acute myeloid leukemia: time to move toward a minimal residual disease-based definition of complete remission? J Clin Oncol 34, 329–336.

    Article  PubMed  Google Scholar 

  • Chang, Y.J., Wang, Y., and Huang, X.J. (2014). Haploidentical stem cell transplantation for the treatment of leukemia: current status. Expert Rev Hematol 7, 635–647.

    Article  CAS  PubMed  Google Scholar 

  • Chang, Y.J., Wang, Y., Liu, Y.R., Xu, L.P., Zhang, X.H., Chen, H., Chen, Y. H., Wang, F.R., Han, W., Sun, Y.Q., et al. (2017). Haploidentical allograft is superior to matched sibling donor allograft in eradicating pretransplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis. J Hematol Oncol 10, 134.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ding, G., and Chen, H. (2016). Adoptive transfer of T cells transduced with a chimeric antigen receptor to treat relapsed or refractory acute leukemia: efficacy and feasibility of immunotherapy approaches. Sci China Life Sci 59, 673–677.

    Article  CAS  PubMed  Google Scholar 

  • Döhner, H., Estey, E.H., Amadori, S., Appelbaum, F.R., Büchner, T., Burnett, A.K., Dombret, H., Fenaux, P., Grimwade, D., Larson, R.A., et al. (2010). Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 115, 453–474.

    Article  CAS  PubMed  Google Scholar 

  • Döhner, H., Estey, E., Grimwade, D., Amadori, S., Appelbaum, F.R., Büchner, T., Dombret, H., Ebert, B.L., Fenaux, P., Larson, R.A., et al. (2017). Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 129, 424–447.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fu, Q., Xu, L., Zhang, X., Wang, Y., Chang, Y., Liu, K., and Huang, X. (2018). Platelet transfusion refractoriness after T-cell-replete haploidentical transplantation is associated with inferior clinical outcomes. Sci China Life Sci 61, 569–577.

    Article  PubMed  Google Scholar 

  • Hamilton, B.K., and Copelan, E.A. (2012). Concise review: the role of hematopoietic stem cell transplantation in the treatment of acute myeloid leukemia. Stem Cells 30, 1581–1586.

    Article  CAS  PubMed  Google Scholar 

  • Liu, J., Wang, Y., Xu, L.P., Liu, D.H., Qin, Y.Z., Chang, Y.J., Liu, K.Y., and Huang, X.J. (2014). Monitoring mixed lineage leukemia expression may help identify patients with mixed lineage leukemia-rearranged acute leukemia who are at high risk of relapse after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 20, 929–936.

    Article  PubMed  Google Scholar 

  • Lv, M., and Huang, X.J. (2015). Fighting against hematological malignancy in China: from unique system to global impact. Sci China Life Sci 58, 1183–1190.

    Article  PubMed  Google Scholar 

  • Mo, X.D., Zhang, X.H., Xu, L.P., Wang, Y., Yan, C.H., Chen, H., Chen, Y. H., Han, W., Wang, F.R., Wang, J.Z., et al. (2017). IFN-α is effective for treatment of minimal residual disease in patients with acute leukemia after allogeneic hematopoietic stem cell transplantation: results of a registry study. Biol Blood Marrow Transplant 23, 1303–1310.

    Article  CAS  PubMed  Google Scholar 

  • O’Donnell, M.R., Abboud, C.N., Altman, J., Appelbaum, F.R., Arber, D.A., Attar, E., Borate, U., Coutre, S.E., Damon, L.E., Goorha, S., et al. (2012). NCCN Clinical Practice Guidelines Acute myeloid leukemia. J Natl Compr Canc Netw 10, 984–1021.

    Article  PubMed  Google Scholar 

  • Przepiorka, D., Weisdorf, D., Martin, P., Klingemann, H.G., Beatty, P., Hows, J., and Thomas, E.D. (1995). 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 15, 825–828.

    CAS  PubMed  Google Scholar 

  • Schetelig, J., Schaich, M., Schäfer-Eckart, K., Hänel, M., Aulitzky, W.E., Einsele, H., Schmitz, N., Rösler, W., Stelljes, M., Baldus, C.D., et al. (2015). Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial. Leukemia 29, 1060–1068.

    Article  CAS  PubMed  Google Scholar 

  • Stelljes, M., Beelen, D.W., Braess, J., Sauerland, M.C., Heinecke, A., Berning, B., Kolb, H.J., Holler, E., Schwerdtfeger, R., Arnold, R., et al. (2011). Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trial. Haematologica 96, 972–979.

    Article  PubMed  PubMed Central  Google Scholar 

  • Versluis, J., Labopin, M., Ruggeri, A., Socie, G., Wu, D., Volin, L., Blaise, D., Milpied, N., Craddock, C., Yakoub-Agha, I., et al. (2017). Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1. Blood Adv 1, 477–485.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang, Y., Liu, D.H., Liu, K.Y., Xu, L.P., Zhang, X.H., Han, W., Chen, H., Chen, Y.H., and Huang, X.J. (2013). Impact of pretransplantation risk factors on post transplantation outcome of patients with acute myeloid leukemia in remission after haploidentical hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 19, 283–290.

    Article  PubMed  Google Scholar 

  • Wang, Y., Liu, Q.F., Xu, L.P., Liu, K.Y., Zhang, X.H., Ma, X., Fan, Z.P., Wu, D.P., and Huang, X.J. (2015). Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study. Blood 125, 3956–3962.

    Article  CAS  PubMed  Google Scholar 

  • Xu, L., Chen, H., Chen, J., Han, M., Huang, H., Lai, Y., Liu, D., Liu, Q., Liu, T., Jiang, M., et al. (2018). The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology. J Hematol Oncol 11, 33.

    Article  PubMed  PubMed Central  Google Scholar 

  • Yan, C.H., Liu, D.H., Liu, K.Y., Xu, L.P., Liu, Y.R., Chen, H., Han, W., Wang, Y., Qin, Y.Z., and Huang, X.J. (2012). Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation. Blood 119, 3256–3262.

    Article  CAS  PubMed  Google Scholar 

  • Yan, C.H., Liu, Q.F., Wu, D.P., Zhang, X., Xu, L.P., Zhang, X.H., Wang, Y., Huang, H., Bai, H., Huang, F., et al. (2017). Prophylactic donor lymphocyte infusion (DLI) followed by minimal residual disease and graftversus- host disease-guided multiple DLIs could improve outcomes after allogeneic hematopoietic stem cell transplantation in patients with refractory/relapsed acute leukemia. Biol Blood Marrow Transplant 23, 1311–1319.

    Article  PubMed  Google Scholar 

  • Zhao, X., Gao, F., Zhang, X., Wang, Y., Xu, L., Liu, K., Zhao, X., Chang, Y., Wei, H., Chen, H., et al. (2016). Improved clinical outcomes of rhGCSF- mobilized blood and marrow haploidentical transplantation compared to propensity score-matched rhG-CSF-primed peripheral blood stem cell haploidentical transplantation: a multicenter study. Sci China Life Sci 59, 1139–1148.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, 100044, China

    Yang Liu, Xiaojun Huang, Qian Fei, Lanping Xu, Xiaohui Zhang, Kaiyan Liu, Yuhong Chen, Huan Chen & Yu Wang

Authors
  1. Yang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiaojun Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qian Fei
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lanping Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiaohui Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kaiyan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yuhong Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Huan Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yu Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yu Wang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, Y., Huang, X., Fei, Q. et al. Comparison analysis between haplo identical stem cell transplantation and matched sibling donor stem cell transplantation for high-risk acute myeloid leukemia in first complete remission. Sci. China Life Sci. 62, 691–697 (2019). https://doi.org/10.1007/s11427-018-9361-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11427-018-9361-2

Keywords

Search

Navigation